Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NECTIN-4-TARGETED BICYCLIC PEPTIDE NUCLIDE LIGAND AND PROBE
Document Type and Number:
WIPO Patent Application WO/2023/098072
Kind Code:
A1
Abstract:
Provided are a Nectin-4-targeted bicyclic peptide nuclide ligand and probe. The ligand has a structure represented by formula I, where X is Lys or Arg; and R is a group represented by formula II, formula III, formula IV or formula V. The probe has high tumor uptake and a high uptake ratio of tumor to muscle, and has good clinical application prospects.

Inventors:
YANG XING (CN)
DUAN XIAOJIANG (CN)
ZHU HUA (CN)
ZHANG NING (CN)
YANG ZHI (CN)
ZHANG JIANHUA (CN)
ZHANG ZHUOCHEN (CN)
Application Number:
PCT/CN2022/103338
Publication Date:
June 08, 2023
Filing Date:
July 01, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV PEKING FIRST HOSPITAL (CN)
International Classes:
C07K7/08; A61K38/00; C07C275/16; C07D257/02
Domestic Patent References:
WO2021028686A12021-02-18
Foreign References:
CN114133434A2022-03-04
CN112566651A2021-03-26
CN112062695A2020-12-11
US20190184043A12019-06-20
Other References:
WEN KAI, HU JI, DENG XUE-SONG, ZHAO HAI-LONG, LUO TIAN-WEI, CHEN MENG-YI, XU LIN, QIN XIANG-YU, YU JING-JING, CUI HAI-PING: "Preliminary Evaluation of Prostate Cancer Molecular Probe 68Ga-DOTA-ANCP-PSMA", JOURNAL OF NUCLEAR AND RADIOCHEMISTRY, vol. 42, no. 4, 31 August 2020 (2020-08-31), pages 292 - 299, XP093068653
CHATTERJEE SUBHAJIT, SINHA SAPTARSHI, KUNDU CHANAKYA NATH: "Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy", EUROPEAN JOURNAL OF PHARMACOLOGY, ELSEVIER SCIENCE, NL, vol. 911, 1 November 2021 (2021-11-01), NL , pages 174516, XP093068652, ISSN: 0014-2999, DOI: 10.1016/j.ejphar.2021.174516
Attorney, Agent or Firm:
BEIJING SICHUANG DACHENG INTELLECTUAL PROPERTY AGENCY CO., LTD. (CN)
Download PDF: